期刊文献+

Biliary drainage strategy of unresectable malignant hilar strictures by computed tomography volumetry 被引量:9

Biliary drainage strategy of unresectable malignant hilar strictures by computed tomography volumetry
暂未订购
导出
摘要 AIM:To identify criteria for predicting successful drainage of unresectable malignant hilar biliary strictures(UMHBS) because no ideal strategy currently exists.METHODS:We examined 78 patients with UMHBS who underwent biliary drainage.Drainage was considered effective when the serum bilirubin level decreased by ≥ 50% from the value before stent placement within 2 wk after drainage, without additional intervention.Complications that occurred within 7 d after stent placement were considered as early complications.Before drainage, the liver volume of each section(lateral and medial sections of the left liver and anterior and posterior sections of the right liver) was measured using computed tomography(CT) volumetry.Drained liver volume was calculated based on the volume of each liver section and the type of bile duct stricture(according to the Bismuth classification).Tumor volume, which was calculated by using CT volumetry, was excluded from the volume of each section.Receiver operating characteristic(ROC) analysis was performed to identify the optimal cutoff values for drained liver volume.In addition, factors associated with the effectiveness of drainage and early complications were evaluated.RESULTS:Multivariate analysis showed that drained liver volume [odds ratio(OR) = 2.92, 95%CI:1.648-5.197; P < 0.001] and impaired liver function(with decompensated liver cirrhosis)(OR = 0.06, 95%CI:0.009-0.426; P = 0.005) were independent factors contributing to the effectiveness of drainage.ROC analysis for effective drainage showed cutoff values of 33% of liver volume for patients with preserved liver function(with normal liver or compensated livercirrhosis)and 50%for patients with impaired liver function(with decompensated liver cirrhosis).The sensitivity and specificity of these cutoff values were82%and 80%for preserved liver function,and 100%and 67%for impaired liver function,respectively.Among patients who met these criteria,the rate of effective drainage among those with preserved liver function and impaired liver function was 90%and 80%,respectively.The rates of effective drainage in both groups were significantly higher than in those who did not fulfill these criteria(P<0.001 and P=0.02,respectively).Drainage-associated cholangitis occurred in 9 patients(12%).A smaller drained liver volume was associated with drainage-associated cholangitis(P<0.01).CONCLUSION:Liver volume drainage≥33%in patients with preserved liver function and≥50%in patients with impaired liver function correlates with effective biliary drainage in UMHBS. AIM:To identify criteria for predicting successful drainage of unresectable malignant hilar biliary strictures(UMHBS) because no ideal strategy currently exists.METHODS:We examined 78 patients with UMHBS who underwent biliary drainage.Drainage was considered effective when the serum bilirubin level decreased by ≥ 50% from the value before stent placement within 2 wk after drainage, without additional intervention.Complications that occurred within 7 d after stent placement were considered as early complications.Before drainage, the liver volume of each section(lateral and medial sections of the left liver and anterior and posterior sections of the right liver) was measured using computed tomography(CT) volumetry.Drained liver volume was calculated based on the volume of each liver section and the type of bile duct stricture(according to the Bismuth classification).Tumor volume, which was calculated by using CT volumetry, was excluded from the volume of each section.Receiver operating characteristic(ROC) analysis was performed to identify the optimal cutoff values for drained liver volume.In addition, factors associated with the effectiveness of drainage and early complications were evaluated.RESULTS:Multivariate analysis showed that drained liver volume [odds ratio(OR) = 2.92, 95%CI:1.648-5.197; P < 0.001] and impaired liver function(with decompensated liver cirrhosis)(OR = 0.06, 95%CI:0.009-0.426; P = 0.005) were independent factors contributing to the effectiveness of drainage.ROC analysis for effective drainage showed cutoff values of 33% of liver volume for patients with preserved liver function(with normal liver or compensated livercirrhosis)and 50%for patients with impaired liver function(with decompensated liver cirrhosis).The sensitivity and specificity of these cutoff values were82%and 80%for preserved liver function,and 100%and 67%for impaired liver function,respectively.Among patients who met these criteria,the rate of effective drainage among those with preserved liver function and impaired liver function was 90%and 80%,respectively.The rates of effective drainage in both groups were significantly higher than in those who did not fulfill these criteria(P<0.001 and P=0.02,respectively).Drainage-associated cholangitis occurred in 9 patients(12%).A smaller drained liver volume was associated with drainage-associated cholangitis(P<0.01).CONCLUSION:Liver volume drainage≥33%in patients with preserved liver function and≥50%in patients with impaired liver function correlates with effective biliary drainage in UMHBS.
出处 《World Journal of Gastroenterology》 SCIE CAS 2015年第16期4946-4953,共8页 世界胃肠病学杂志(英文版)
关键词 BILIARY drainage Computed tomographyvolumetry HILAR BILIARY STRICTURE Cholangiocarcinoma Liver function CHOLANGITIS Biliary drainage Computed tomography volumetry Hilar biliary stricture Cholangiocarcinoma Liver function Cholangitis
  • 相关文献

参考文献27

  • 1Saluja SS, Gulati M, Garg PK, Pal H, Pal S, Sahni P, ChattopadhyayTK. Endoscopic or percutaneous biliary drainage for gallbladdercancer: a randomized trial and quality of life assessment. ClinGastroenterol Hepatol 2008; 6: 944-950.e3 [PMID: 18585976 DOI:10.1016/j.cgh.2008.03.028].
  • 2Paik WH, Park YS, Hwang JH, Lee SH, Yoon CJ, Kang SG, LeeJK, Ryu JK, Kim YT, Yoon YB. Palliative treatment with selfexpandablemetallic stents in patients with advanced type III orIV hilar cholangiocarcinoma: a percutaneous versus endoscopicapproach. Gastrointest Endosc 2009; 69: 55-62 [PMID: 18657806DOI: 10.1016/j.gie.2008.04.005].
  • 3Ducreux M, Liguory C, Lefebvre JF, Ink O, Choury A, Fritsch J,Bonnel D, Derhy S, Etienne JP. Management of malignant hilarbiliary obstruction by endoscopy. Results and prognostic factors. DigDis Sci 1992; 37: 778-783 [PMID: 1373361].
  • 4Cheng JL, Bruno MJ, Bergman JJ, Rauws EA, Tytgat GN,Huibregtse K. Endoscopic palliation of patients with biliaryobstruction caused by nonresectable hilar cholangiocarcinoma:efficacy of self-expandable metallic Wallstents. Gastrointest Endosc2002; 56: 33-39 [PMID: 12085032].
  • 5Rerknimitr R, Kladcharoen N, Mahachai V, Kullavanijaya P. Resultof endoscopic biliary drainage in hilar cholangiocarcinoma. J ClinGastroenterol 2004; 38: 518-523 [PMID: 15220688].
  • 6Wagner HJ, Knyrim K, Vakil N, Klose KJ. Plastic endoprosthesesversus metal stents in the palliative treatment of malignant hilarbiliary obstruction. A prospective and randomized trial. Endoscopy1993; 25: 213-218 [PMID: 7686100].
  • 7Perdue DG, Freeman ML, DiSario JA, Nelson DB, Fennerty MB,Lee JG, Overby CS, Ryan ME, Bochna GS, Snady HW, Moore JP.Plastic versus self-expanding metallic stents for malignant hilarbiliary obstruction: a prospective multicenter observational cohortstudy. J Clin Gastroenterol 2008; 42: 1040-1046 [PMID: 18719507DOI: 10.1097/MCG.0b013e31815853e0].
  • 8Sangchan A, Kongkasame W, Pugkhem A, Jenwitheesuk K,Mairiang P. Efficacy of metal and plastic stents in unresectablecomplex hilar cholangiocarcinoma: a randomized controlled trial.Gastrointest Endosc 2012; 76: 93-99 [PMID: 22595446 DOI:10.1016/j.gie.2012.02.048].
  • 9Raju RP, Jaganmohan SR, Ross WA, Davila ML, Javle M, Raju GS,Lee JH. Optimum palliation of inoperable hilar cholangiocarcinoma:comparative assessment of the efficacy of plastic and self-expandingmetal stents. Dig Dis Sci 2011; 56: 1557-1564 [PMID: 21222156DOI: 10.1007/s10620-010-1550-5].
  • 10Mukai T, Yasuda I, Nakashima M, Doi S, Iwashita T, Iwata K, KatoT, Tomita E, Moriwaki H. Metallic stents are more efficacious thanplastic stents in unresectable malignant hilar biliary strictures: arandomized controlled trial. J Hepatobiliary Pancreat Sci 2013; 20:214-222 [PMID: 22415652 DOI: 10.1007/s00534-012-0508-8].

同被引文献72

引证文献9

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部